Diagnostic Accuracy of Triphasic Bone Scan and SPECT/CT in Foot and Ankle Osteoarthritis
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAssiut University
About this trial
This cross-sectional study aims to assess the diagnostic accuracy of triphasic bone scintigraphy and SPECT/CT in evaluating foot and ankle osteoarthritis, using magnetic resonance imaging (MRI) as the reference standard, and to determine the affected joints.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients presenting with chronic foot and/or ankle pain suspected to be due to osteoarthritis
Clinical and/or radiographic suspicion of foot or ankle osteoarthritis
Disqualifiers
Age < 18 years
Previous surgery or joint replacement of the affected foot or ankle
Bone tumors or metastatic bone disease
Active osteomyelitis or septic arthritis
Trial population
Adult patients with chronic foot and/or ankle pain suspected of osteoarthritis referred to the Nuclear Medicine Unit at Assiut University Hospital who meet the eligibility criteria.
Trial design
Design model
Case-only
Time perspective
Cross-sectional
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Diagnostic accuracy of triphasic bone scan and SPECT/CT
Sensitivity, specificity, positive predictive value, and negative predictive value of triphasic bone scintigraphy and SPECT/CT for detecting foot and ankle osteoarthritis, using MRI as the reference standard.
Time frame
BaselineSecondary outcomes
1
Identification of affected joints
Determination of the specific joints affected by osteoarthritis in the foot and ankle based on SPECT/CT and MRI findings.
Time frame
BaselineLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: